
Charles Goodman
Examiner (ID: 6936)
| Most Active Art Unit | 3724 |
| Art Unit(s) | 3724, 3204, 3727 |
| Total Applications | 686 |
| Issued Applications | 469 |
| Pending Applications | 42 |
| Abandoned Applications | 175 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18581624
[patent_doc_number] => 20230263876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => COMPOSITIONS AND METHODS RELATING TO TYPHOID TOXIN SUBUNIT PLTC
[patent_app_type] => utility
[patent_app_number] => 18/005444
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005444
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/005444 | COMPOSITIONS AND METHODS RELATING TO TYPHOID TOXIN SUBUNIT PLTC | Jul 14, 2021 | Pending |
Array
(
[id] => 17243532
[patent_doc_number] => 20210363275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => METHODS, COMPOSITIONS AND KITS FOR TREATING A SUBJECT USING A RECOMBINANT HETEROMULTIMERIC NEUTRALIZING BINDING PROTEIN
[patent_app_type] => utility
[patent_app_number] => 17/371762
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37250
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17371762
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/371762 | Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding protein | Jul 8, 2021 | Issued |
Array
(
[id] => 17412745
[patent_doc_number] => 20220047649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER USING BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/359375
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12630
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17359375
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/359375 | COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER USING BACTERIA | Jun 24, 2021 | Abandoned |
Array
(
[id] => 17624950
[patent_doc_number] => 20220159965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => COMPOSITIONS COMPRISING RECOMBINANT BACILLUS CELLS AND A FUNGICIDE
[patent_app_type] => utility
[patent_app_number] => 17/356941
[patent_app_country] => US
[patent_app_date] => 2021-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26607
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17356941
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/356941 | Compositions comprising recombinant | Jun 23, 2021 | Issued |
Array
(
[id] => 19256883
[patent_doc_number] => 12016912
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Compositions comprising recombinant
[patent_app_type] => utility
[patent_app_number] => 17/356958
[patent_app_country] => US
[patent_app_date] => 2021-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 27937
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17356958
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/356958 | Compositions comprising recombinant | Jun 23, 2021 | Issued |
Array
(
[id] => 19815074
[patent_doc_number] => 20250073281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-06
[patent_title] => LACTOBACILLUS REUTERI HAVING IMPROVED ANTI-AGING AND HAIR HEALTH ENHANCEMENT EFFECTS, AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/555869
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18555869
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/555869 | LACTOBACILLUS REUTERI HAVING IMPROVED ANTI-AGING AND HAIR HEALTH ENHANCEMENT EFFECTS, AND APPLICATION THEREOF | Jun 20, 2021 | Pending |
Array
(
[id] => 18701554
[patent_doc_number] => 11788053
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Microorganisms and methods for reducing bacterial contamination
[patent_app_type] => utility
[patent_app_number] => 17/347413
[patent_app_country] => US
[patent_app_date] => 2021-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 28107
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17347413
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/347413 | Microorganisms and methods for reducing bacterial contamination | Jun 13, 2021 | Issued |
Array
(
[id] => 19373920
[patent_doc_number] => 12065469
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals
[patent_app_type] => utility
[patent_app_number] => 17/345576
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 61441
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 327
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17345576
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/345576 | De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals | Jun 10, 2021 | Issued |
Array
(
[id] => 17126205
[patent_doc_number] => 20210300973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => LACTOBACILLUS ACIDOPHILUS SURFACE LAYER PROTEIN A (SLPA) AS A THERAPEUTIC AGENT FOR THE TREATMENT OF INFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/340141
[patent_app_country] => US
[patent_app_date] => 2021-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16281
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17340141
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/340141 | LACTOBACILLUS ACIDOPHILUS SURFACE LAYER PROTEIN A (SLPA) AS A THERAPEUTIC AGENT FOR THE TREATMENT OF INFLAMMATORY DISEASES | Jun 6, 2021 | Abandoned |
Array
(
[id] => 17110070
[patent_doc_number] => 20210290667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => Mutant Bordetella Strains and Methods of Use
[patent_app_type] => utility
[patent_app_number] => 17/337367
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17337367
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/337367 | Mutant Bordetella Strains and Methods of Use | Jun 1, 2021 | Abandoned |
Array
(
[id] => 19535043
[patent_doc_number] => 12127576
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-29
[patent_title] => Specific bacteria for their use as a medicament, in particular for controlling excess weight, obesity, cardiometabolic diseases and inflammatory bowel diseases
[patent_app_type] => utility
[patent_app_number] => 17/331776
[patent_app_country] => US
[patent_app_date] => 2021-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6914
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17331776
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/331776 | Specific bacteria for their use as a medicament, in particular for controlling excess weight, obesity, cardiometabolic diseases and inflammatory bowel diseases | May 26, 2021 | Issued |
Array
(
[id] => 18449559
[patent_doc_number] => 20230190835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => PROBIOTIC BACTERIA FOR TREATING ALZHEIMER'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/926164
[patent_app_country] => US
[patent_app_date] => 2021-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17926164
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/926164 | PROBIOTIC BACTERIA FOR TREATING ALZHEIMER'S DISEASE | May 17, 2021 | Abandoned |
Array
(
[id] => 17227176
[patent_doc_number] => 20210353732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => USE OF TLR4 MODULATOR IN THE TREATMENT OF COCCIDIOSIS
[patent_app_type] => utility
[patent_app_number] => 17/320706
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5591
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320706
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/320706 | USE OF TLR4 MODULATOR IN THE TREATMENT OF COCCIDIOSIS | May 13, 2021 | Abandoned |
Array
(
[id] => 18701342
[patent_doc_number] => 11787841
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Rationally-designed mutations to the thrA gene for enhanced lysine production in
[patent_app_type] => utility
[patent_app_number] => 17/319006
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6633
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319006
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/319006 | Rationally-designed mutations to the thrA gene for enhanced lysine production in | May 11, 2021 | Issued |
Array
(
[id] => 17741495
[patent_doc_number] => 11389542
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-07-19
[patent_title] => Shiga toxin a subunit effector polypeptides, Shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation
[patent_app_type] => utility
[patent_app_number] => 17/314563
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 20
[patent_no_of_words] => 101882
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17314563
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/314563 | Shiga toxin a subunit effector polypeptides, Shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation | May 6, 2021 | Issued |
Array
(
[id] => 17354595
[patent_doc_number] => 20220015391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => METHODS OF IMPROVING DESIRABLE TRAITS IN FOWL
[patent_app_type] => utility
[patent_app_number] => 17/306313
[patent_app_country] => US
[patent_app_date] => 2021-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17306313
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/306313 | METHODS OF IMPROVING DESIRABLE TRAITS IN FOWL | May 2, 2021 | Abandoned |
Array
(
[id] => 17124423
[patent_doc_number] => 20210299191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/228146
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54162
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17228146
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/228146 | COMPOSITIONS AND METHODS | Apr 11, 2021 | Abandoned |
Array
(
[id] => 18909310
[patent_doc_number] => 11872273
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-16
[patent_title] => Proteins and immunizing compositions containing
[patent_app_type] => utility
[patent_app_number] => 17/226761
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 39
[patent_no_of_words] => 32052
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17226761
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/226761 | Proteins and immunizing compositions containing | Apr 8, 2021 | Issued |
Array
(
[id] => 18421588
[patent_doc_number] => 20230176052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => MYCOPLASMA PNEUMONIAE IMMUNOASSAY METHOD AND IMMUNOASSAY INSTRUMENT
[patent_app_type] => utility
[patent_app_number] => 17/917622
[patent_app_country] => US
[patent_app_date] => 2021-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3848
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917622
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/917622 | MYCOPLASMA PNEUMONIAE IMMUNOASSAY METHOD AND IMMUNOASSAY INSTRUMENT | Apr 5, 2021 | Pending |
Array
(
[id] => 18434359
[patent_doc_number] => 20230181653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => COMPOSITIONS FOR METABOLIC HEALTH
[patent_app_type] => utility
[patent_app_number] => 17/916242
[patent_app_country] => US
[patent_app_date] => 2021-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16952
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916242
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/916242 | COMPOSITIONS FOR METABOLIC HEALTH | Apr 4, 2021 | Abandoned |